Home Research Staff

Staff

Dr. med. Konstantin Mechler

Phone: +49 621 1703-4502

e-mail

D 7, 27, Raum 5

Publications in peer reviewed journals since 2006

TOP 5 publications:

  1. Mechler K, Banaschewski T, Hohmann S, Häge A. Evidence-based pharmacological treatment options for ADHD in children and adolescents. Pharmacol Ther. 2021 Jun 23. [Epub ahead of print]:107940.
  2. Purper-Ouakil D, Blasco-Fontecilla H, Ros T, Acquaviva E, Banaschewski T, Baumeister S, Bousquet E, Bussalb A, Delhaye M, Delorme R, Drechsler R, Goujon A, Häge A, Kaiser A, Mayaud L, Mechler K, Menache C, Revol O, Tagwerker F, Walitza S, Werling AM, Bioulac S, Brandeis D. Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trial. J Child Psychol Psychiatry. 2021 Jun 24. [Epub ahead of print].
  3. Mechler K, Mountford WK, Hoffmann GF, Ries M. Ultra-orphan diseases: a quantitative analysis of the natural history of molybdenum cofactor deficiency. Genet Med. 2015 17(12):965-70. Epub 2015 Mar 12.
  4. Hinderhofer K, Mechler K, Hoffmann GF, Lampert A, Mountford WK, Ries M. Critical appraisal of genotype assessment in molybdenum cofactor deficiency. J Inherit Metab Dis. 2017 40(6):801-811. Epub 2017 Sep 12.
  5. Mechler K, Mountford WK, Hoffmann GF, Ries M. Pressure for drug development in lysosomal storage disorders - a quantitative analysis thirty years beyond the US orphan drug act. Orphanet J Rare Dis. 2015 10(1):46.


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de